{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:28:27Z","timestamp":1784608107196,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003448","name":"General Secretariat for Research and Innovation","doi-asserted-by":"publisher","award":["TAEDR-0535850"],"award-info":[{"award-number":["TAEDR-0535850"]}],"id":[{"id":"10.13039\/501100003448","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013128","name":"Multiple System Atrophy Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jns.2025.123731","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:42:03Z","timestamp":1760661723000},"page":"123731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Progressive supranuclear palsy against everyone else: a look into the specificity of MRI markers"],"prefix":"10.1016","volume":"478","author":[{"given":"Vasilios C.","family":"Constantinides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Evgenia","family":"Brinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Kapsali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Giagkou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Velonakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sokratis G.","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George P.","family":"Paraskevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Kapaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Stefanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.jns.2025.123731_bb0005","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/mds.26054","article-title":"The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases","volume":"29","author":"Respondek","year":"2014","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.jns.2025.123731_bb0010","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2025.123731_bb0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.parkreldis.2019.10.012","article-title":"Are the international Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?","volume":"69","author":"Shoeibi","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.jns.2025.123731_bb0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mds.27872","article-title":"Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies","volume":"35","author":"Respondek","year":"2020","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.jns.2025.123731_bb0025","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/archneur.58.7.1076","article-title":"Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy","volume":"58","author":"Warmuth-Metz","year":"2001","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2025.123731_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0404.2006.00767.x","article-title":"Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging","volume":"116","author":"Cosottini","year":"2007","journal-title":"Acta Neurol. Scand."},{"issue":"2","key":"10.1016\/j.jns.2025.123731_bb0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10072-017-3212-2","article-title":"Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy","volume":"39","author":"Constantinides","year":"2018","journal-title":"Neurol. Sci."},{"issue":"12","key":"10.1016\/j.jns.2025.123731_bb0040","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1212\/01.WNL.0000165960.04422.D0","article-title":"New and reliable MRI diagnosis for progressive supranuclear palsy","volume":"64","author":"Oba","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2025.123731_bb0045","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1148\/radiol.2453061703","article-title":"MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy","volume":"246","author":"Quattrone","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.jns.2025.123731_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2018.07.016","article-title":"A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson\u2019s disease","volume":"54","author":"Quattrone","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.jns.2025.123731_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","article-title":"Distribution patterns of tau pathology in progressive supranuclear palsy","volume":"140","author":"Kovacs","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.jns.2025.123731_bb0060","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/WNO.0000000000001393","article-title":"Clinical correlation between vertical gaze palsy and midbrain volume in progressive Supranuclear palsy","volume":"42","author":"Buch","year":"2022","journal-title":"J. Neuroophthalmol."},{"issue":"12","key":"10.1016\/j.jns.2025.123731_bb0065","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1212\/WNL.0000000000003125","article-title":"MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism","volume":"87","author":"Quattrone","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2025.123731_bb0070","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/ane.13205","article-title":"Midbrain morphology in idiopathic normal pressure hydrocephalus: a progressive supranuclear palsy mimic","volume":"141","author":"Constantinides","year":"2020","journal-title":"Acta Neurol. Scand."},{"issue":"11","key":"10.1016\/j.jns.2025.123731_bb0075","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/mds.28330","article-title":"MRI linear measurements in Normal pressure hydrocephalus versus progressive Supranuclear palsy","volume":"35","author":"Ugga","year":"2020","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2025.123731_bb0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/jon.12932","article-title":"Midbrain area and the hummingbird sign from brain MRI in progressive supranuclear palsy and idiopathic normal pressure hydrocephalus","volume":"32","author":"Virhammar","year":"2022","journal-title":"J. Neuroimaging"},{"issue":"1","key":"10.1016\/j.jns.2025.123731_bb0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12883-023-03151-4","article-title":"Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson\u2019s disease on MRI","volume":"23","author":"Muller","year":"2023","journal-title":"BMC Neurol."},{"issue":"7","key":"10.1016\/j.jns.2025.123731_bb0090","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/ene.13314","article-title":"The midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias","volume":"24","author":"Silsby","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2025.123731_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3233\/JAD-2010-100333","article-title":"A combination of CSF tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy","volume":"22","author":"Borroni","year":"2010","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"2","key":"10.1016\/j.jns.2025.123731_bb0100","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-170743","article-title":"Aphasia in progressive Supranuclear palsy: as severe as progressive non-fluent aphasia","volume":"61","author":"Burrell","year":"2018","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"3","key":"10.1016\/j.jns.2025.123731_bb0105","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.psychres.2013.08.045","article-title":"Behavioral abnormalities in progressive supranuclear palsy","volume":"210","author":"Gerstenecker","year":"2013","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.jns.2025.123731_bb0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mds.22946","article-title":"Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis","volume":"25","author":"Rohrer","year":"2010","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2025.123731_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3988\/jcn.2010.6.3.148","article-title":"Behavioral changes as the earliest clinical manifestation of progressive supranuclear palsy","volume":"6","author":"Han","year":"2010","journal-title":"J. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2025.123731_bb0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2025.123731_bb0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2176\/nmc.st.2020-0292","article-title":"Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (third edition): endorsed by the Japanese Society of Normal Pressure Hydrocephalus","volume":"61","author":"Nakajima","year":"2021","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"issue":"3","key":"10.1016\/j.jns.2025.123731_bb0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1440-1789.2000.00334.x","article-title":"An autopsy case of Alzheimer\u2019s disease with a progressive supranuclear palsy overlap","volume":"20","author":"Urasaki","year":"2000","journal-title":"Neuropathology"},{"issue":"3","key":"10.1016\/j.jns.2025.123731_bb0135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JAD-131508","article-title":"An 85-year old male with levodopa-responsive parkinsonism followed by dementia and supranuclear ophthalmoplegia caused by alzheimer-type pathology without Lewy bodies","volume":"39","author":"Kasahata","year":"2014","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"1","key":"10.1016\/j.jns.2025.123731_bb0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0304-3940(92)90643-L","article-title":"Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer\u2019s changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles","volume":"136","author":"Cruz-Sanchez","year":"1992","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.jns.2025.123731_bb0145","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2025.123731_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29005","article-title":"The Movement Disorder Society criteria for the diagnosis of multiple system atrophy","author":"Wenning","year":"2022","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.jns.2025.123731_bb0155","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2025.123731_bb0160","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the international working group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol."},{"issue":"Pt 9","key":"10.1016\/j.jns.2025.123731_bb0165","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.jns.2025.123731_bb0170","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jns.2025.123731_bb0175","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jalz.2017.01.014","article-title":"Consensus classification of posterior cortical atrophy","volume":"13","author":"Crutch","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2025.123731_bb0180","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A5618","article-title":"MRI Planimetry and magnetic resonance parkinsonism index in the differential diagnosis of patients with parkinsonism","author":"Constantinides","year":"2018","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"3","key":"10.1016\/j.jns.2025.123731_bb0185","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/mds.23529","article-title":"Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease","volume":"26","author":"Morelli","year":"2011","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.jns.2025.123731_bb0190","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/mds.28992","article-title":"Development and validation of automated magnetic resonance parkinsonism index 2.0 to distinguish progressive Supranuclear palsy-parkinsonism from Parkinson\u2019s disease","volume":"37","author":"Quattrone","year":"2022","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jns.2025.123731_bb0195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/nimg.1998.0395","article-title":"Cortical surface-based analysis. I. Segmentation and surface reconstruction","volume":"9","author":"Dale","year":"1999","journal-title":"Neuroimage"},{"key":"10.1016\/j.jns.2025.123731_bb0200","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuroimage.2015.02.065","article-title":"Bayesian segmentation of brainstem structures in MRI","volume":"113","author":"Iglesias","year":"2015","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.jns.2025.123731_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/neurolint16010001","article-title":"Planimetric and volumetric brainstem MRI markers in progressive Supranuclear palsy, multiple system atrophy, and Corticobasal syndrome. A Systematic Review and Meta-Analysis","volume":"16","author":"Brinia","year":"2023","journal-title":"Neurol. Int."},{"key":"10.1016\/j.jns.2025.123731_bb0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.parkreldis.2017.10.020","article-title":"MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP","volume":"46","author":"Mangesius","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"issue":"14","key":"10.1016\/j.jns.2025.123731_bb0215","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/mds.23351","article-title":"Diagnostic accuracy of the magnetic resonance parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson\u2019s disease and the Parkinson variant of multiple system atrophy","volume":"25","author":"Hussl","year":"2010","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jns.2025.123731_bb0220","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/mds.23293","article-title":"MRI measurements of brainstem structures in patients with Richardson\u2019s syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson\u2019s disease","volume":"26","author":"Longoni","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2025.123731_bb0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.parkreldis.2017.05.002","article-title":"Magnetic resonance parkinsonism index and midbrain to pons ratio: which index better distinguishes progressive Supranuclear palsy patients with a low degree of diagnostic certainty from patients with Parkinson disease?","volume":"41","author":"Nigro","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.jns.2025.123731_bb0230","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3174\/ajnr.A5618","article-title":"MRI Planimetry and magnetic resonance parkinsonism index in the differential diagnosis of patients with parkinsonism","volume":"39","author":"Constantinides","year":"2018","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/j.jns.2025.123731_bb0235","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.neuroimage.2003.09.070","article-title":"Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration","volume":"21","author":"Groschel","year":"2004","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.jns.2025.123731_bb0240","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/01.wnl.0000203342.77115.bf","article-title":"Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy","volume":"66","author":"Groschel","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123731_bb0245","article-title":"Annual percentage change of MR parkinsonism index in progressive supranuclear palsy: a feasibility study","author":"Wang","year":"2025","journal-title":"Eur. Radiol."},{"issue":"8","key":"10.1016\/j.jns.2025.123731_bb0250","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/jnnp-2013-307035","article-title":"Validation of the new consensus criteria for the diagnosis of corticobasal degeneration","volume":"85","author":"Alexander","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2025.123731_bb0255","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.pjnns.2018.06.002","article-title":"Difficulties in the diagnosis of four repeats (4R) tauopathic parkinsonian syndromes","volume":"52","author":"Alster","year":"2018","journal-title":"Neurol. Neurochir. Pol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2500351X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2500351X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T01:06:05Z","timestamp":1766106365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X2500351X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":51,"alternative-id":["S0022510X2500351X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123731","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive supranuclear palsy against everyone else: a look into the specificity of MRI markers","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123731"}}